The Notice is hereby given that the Trading Window shall remain closed under the Code of the Company from 01/04/2026 untill the expiry of 48 hours from the date of declaration of Audited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mahamaya Lifesciences has informed BSE that its trading window will be closed starting April 1, 2026, until 48 hours after the declaration of audited financial results (standalone and consolidated) for FY ending March 31, 2026. During this period, all insiders, designated persons, and their immediate relatives are prohibited from buying or selling the company's shares. The board meeting date to approve the audited results will be communicated separately. This is a standard compliance step under SEBI's Prohibition of Insider Trading Regulations, 2015. The intimation was signed by Shilpi Bhardwaj, Company Secretary & Compliance Officer, on March 30, 2026.
This is a routine SEBI-mandated filing with no material impact on retail shareholders. It signals that audited FY26 results will be announced in the coming weeks, which may be a catalyst for stock movement depending on the numbers disclosed.